Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Organogenesis ORG -- Ignore unavailable to you. Want to Upgrade?

To: Bruce Cullen who wrote (1122)	8/28/1998 9:08:00 AM
From: CMason	Read Replies (2) \| Respond to of 1223

Who are you to tell me how to write a ticker symbol? Oh, I know you, you were one who called for a short squeeze of ORG when it was at 30! Looks like it won't be in double digits pretty soon. . . even in a down market that's poor performance. SEEK is losing money, just like ORG. Tiny sales/share (just like). They do have a cash pile going for them, but it's still only $2/share. Lots of actual and potential competitors, which in a way is worse than the situation ORG faces (since the FDA approval process tends to limit competition). Zero may be an exaggeration, but SEEK is way overvalued on fundamentals at the current price level. If the market is going to fall broadly because of the Russia/Asia/Latin America factors, the internet stocks have farther to fall than most. Any bets on when ORG will hit the nines?